Checked.be · Company dossierhttps://checked.be/en/c/mithra-pharmaceuticals-cdmo-0534912933 · as of 16-10-2026
MITHRA PHARMACEUTICALS CDMO
Open bankruptcy
Public limited company · founded 2013Rue Saint-Georges 5, 4000 Liège, BelgiumKBO/BCE: BE 0534.912.933
Summary
A bankruptcy procedure is open for MITHRA PHARMACEUTICALS CDMO according to publications in the Belgian Official Gazette. The file additionally contains 1 judicial reorganisation. The 2022 annual accounts show negative equity (-€14.6m) and a net result of -€14.6m.
passed on 9 August 2024Fifteen days after the publication in the Official Gazette.art. XX.108, Code of Economic Law
File the claim in RegSol, the Belgian insolvency register, until
passed on 18 August 2024art. XX.104 and XX.155, Code of Economic Law
First verification report
passed on 29 August 2024Reclaim goods that are still yours, such as goods delivered under retention of title, before this day.art. XX.104 and XX.194, Code of Economic Law
Late claim until
passed on 19 July 2025A late claim shares only in what has not yet been paid out, and you bear its costs.art. XX.165, Code of Economic Law
Trustees
Yves GodfroidRue Des Augustins 32, 4000 Liege 1yves.godfroid@henry-mersch.be
Francois MinonRue Des Augustins 32, 4000 Liege 1- mersch.be
What to do now
The deadlines to file your claim have passed, including for a late claim: that was possible until a year after the judgment.
Ask the trustee whether anything will still be paid out and whether your claim was admitted.
Follow the file in RegSol: the trustee's reports appear there.
Ask your accountant about the VAT on the unpaid invoices: in a bankruptcy it can be recovered, subject to conditions.
The judgment is more than a year old: the deadline for a late claim (art. XX.165, Code of Economic Law) has passed too.
General information, not legal advice. If in doubt, the trustee, your lawyer or your accountant can help.Creditor guide for this company
Embed in an article
Writing about this bankruptcy? Embed the MITHRA PHARMACEUTICALS CDMO company card in your article: name, enterprise number, its status in the KBO and the latest annual accounts, with a link to this dossier.
Preview
The preview appears here.
Stays current: the status follows the register, the figures are those of the latest filed accounts. No Checked score or verdict.
Light on your page: one small script and one data request, also answered from a cache; no cookies, no tracking.
Where scripts do not run (a newsletter, a feed reader) a plain link remains.
Overview
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE 21201
2 sites
Size
€26.7mturnover 2022
Staff
168.7 FTE
Equity
-€14.6m
Loss
-€14.6m
Financial health
Open bankruptcy: no score
Structure
Parent
Mithra Pharmaceuticals · 99%
0 of 17 deeds read
Signalsraises riskOpen bankruptcyneutralLatest accounts filed on timeShow the evidence
Signals
Two signals.
raises riskneutral
raises risk · Open bankruptcy
Active bankruptcy procedure in the Belgian Official Gazette. Claims are handled by the appointed trustee. The KBO register also records: open bankruptcy.
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 16 days before the deadline; the sector median (NACE 21) for financial year 2022 is 13 days before the deadline, and 34% of those companies filed late.
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
Supervising judge replacedEnterprise Court of Liège, Liège…